Pemphigus vulgaris (PV) is a common blistering disease in Western countries but neonatal pemphigus (NP) is rare.1,3,5,6 It is characterized by multiple skin and mucosal erosions and is caused by tranplacental passage of maternal antibodies against desmoglein.3 It heals spontaneously in two to three weeks.
CASE
A 3-hour-old baby boy was referred with multiple skin erosions on the left side of the neck, upper left chest and groin without oral involvement (Figure 1A). He was born by normal vaginal delivery without complication with an APGAR score of 8 and 9 at 1 and 5 minutes, respectively, and a weight of 2.57 kg. His mother was known to have PV since 1999, which was proven by biopsy and immunofluorescence. The product of her first pregnancy in 1999 was a baby boy with multiple erosions. The first baby was diagnosed with NP based on the results of a skin biopsy and immunofluorescence. The erosions healed spontaneously in two weeks. The mother was treated with prednisone, and later dapsone was added. She went into complete remission. She went off treatment in July 2001 and developed a new flare of PV in June 2005 during her second pregnancy. She was treated with prednisone 40 mg every other day. Physical examination of the second baby showed multiple erosions over the left side of the neck, shoulder and groin. Skin biopsy was refused by the parents and indirect immunofluorescence showed 1:10. He was treated with topical fucidin and 1% hydrocortisone, and discharged three days after delivery in good condition. At the age of four weeks, he had complete clearance (Figure 1B).
Figure 1a.
At birth, multiple eroded vesicles at upper chest and left side of the neck.
Figure 1b.
At age four weeks with complete healing.
DISCUSSION
PV is the most common form of pemphigus.5 It is usually seen in the fifth decade of life.2,5 Neonatal PV is a rare disease1,3,6 seen soon after birth and characterized by cutaneous, mucosal or mucocutaneous erosions. PV is diagnosed by histological and immunofluorescence studies. Routine histology will show epidermal basal cell vacuolization and spongiosis with exocytosis of polymorphonuclear leucocytes and eosinophils. Immunofluorescence will show IgG and C3 deposition. Indirect immunofluorescence is positive in patients with active disease. A high titre indicates active disease. 2 It usually resolves spontaneously in 2 to 3 weeks.2–5,7,9,12,13,19–21
Neonatal PV results from transplacental passage of IgG maternal autoantibodies, mainly class 4, against desmoglein 3 (Dsg3), a transmembrane glycoprotein of the cadherin family.1,3,4,5,7,8,11,20,23–27 More than 21 cases of neonatal PV have been reported (Table 1), with the first proven one in 1975 by Rucco et al.28 However, there are only 3 reported cases of pemphigus foliaceus (PF).15–17 This difference in incidence may be related to the distribution of Dsg1 and 3 in neonatal skin. Dsg1, the protein affected in PF, is present throughout the epidermis in both adults and neonates, while type 3 is present in the basal and intermediate suprabasal layer in adults, but throughout the epidermis in neonates. So the frequency of neonatal PF is less than PV in babies born to mothers with pemphigus based on the desmoglein compensation theory.5,18 This is supported by at least 18 cases of pregnant women with PF who delivered babies free of the disease.29,30 There is no correlation between the titer of maternal PV antibodies and the presentation of the disease in neonates.2,5,6 This is supported by cases of neonatal PV from mothers with no active disease5,9,31 and cases of healthy neonates born to mothers with highly active disease.4–6,16,17,32–36 The mother might have only oral disease while the baby has both oral and cutaneous involvement.5,36 Stillbirths have been also reported. 23,24,31
Table 1.
Reported cases of neonatal pemphigus vulgaris.
Reference number | Mother’s Disease | Recovery Duration | Treatment | DIF** | IDIF* | Site | Sex |
---|---|---|---|---|---|---|---|
1 | Severe | 2 weeks | Like above | IgG and C3 | 1/160 | Skin and oral cavity | F |
3 | Mild | 2 weeks | Emollient and mupirocin | IgG and C3 | 1/160 | Skin and tongue | F |
6 | Unknown | 2 weeks | Like above | NA | NA | Skin | F |
7 | Mild | 2 weeks | Like above | IgG and C3 | 1/160 | Skin | M |
8 | Unknown | 3 weeks | Like above | NA | 1/20 | Skin | F |
9 | Mild | 2 weeks | No treatment | IgG and C3 | 1/40 | Skin and occipit | M |
10 | Mild | 2 weeks | Emollient and mupirocin | IgG and C3 | 1:80 | Skin | F |
12 | Severe | 2 weeks | No treatment | IgG | 1/20 | Oral | M |
13 | Mild | 3 weeks | No treatment | NA | 1/20 | Skin, tongue and scalp | F |
15 | Unknown | 3 weeks | Like above | IgG | 1/32 | Skin and occipit | M |
22 | Mild | 2 weeks | No treatment | IgG | NA | Skin | F |
34 | Unknown | 2 weeks | Like above | IgG and C3 | Neg | Skin and scalp | F |
Indirect immunoflurescence
direct immunoflurescence
Rx: treatment, NA: Not available, Neg: negative result, M: male, F: female
REFERENCES
- 1.Shieh S, Frang YV, Becker JL, Holm A, Beutner EH, Helm TN. Pemphigus, pregnancy and plasma-pheresis. Cutis. 2004 May;73(5):327–9. [PubMed] [Google Scholar]
- 2.Bjarnason B, Flosadottir E. Childhood, neonatal and stillbirth pemphigus vulgaris. Int J Dermatol. 1999;38:680–688. doi: 10.1046/j.1365-4362.1999.00764.x. [DOI] [PubMed] [Google Scholar]
- 3.Chowdhury MM, Natarajan S. Neonatal pemphigus vulgaris associated with mild oral pemphigus vulgaris in the mother during pregnancy. Br J Dermatol. 1998 Sep;139(3):500–3. doi: 10.1046/j.1365-2133.1998.02418.x. [DOI] [PubMed] [Google Scholar]
- 4.Singalavanija S, Limpongsanurak W. Immunobullous disease in Thai children. J Med Assoc Thai. 2003 Aug;86(Suppl 3):S681–8. [PubMed] [Google Scholar]
- 5.Campo-Voegeli C, Muniz F, Mascaro JM, et al. Neonatal pemphigus vulgaris with extensive mucocutaneous lesions from a mother with oral pemphigus vulgaris. Br J Dermatol. 2002 Oct;147(4):801–5. doi: 10.1046/j.1365-2133.2002.04969.x. [DOI] [PubMed] [Google Scholar]
- 6.Kalayciyan A, Engin B, Serdaroglu S, Mat C, Aydemir EH, Kotogyan A. Br J Dermatol. 2002 Aug;147(2):396–7. doi: 10.1046/j.1365-2133.2002.48299.x. [DOI] [PubMed] [Google Scholar]
- 7.Parlowsky T, Welzel J, Amagai M, Zillikens D, Wygold T. Neonatal pemphigus vulgaris: IgG4 autoantibodies to desmoglein 3 induce skin blisters in newborns. J Am Acad Dermatol. 2003 Apr;48(4):623–5. doi: 10.1067/mjd.2003.170. [DOI] [PubMed] [Google Scholar]
- 8.Ding X, Diaz LA, Fairley JA, Giudice Gj, Liu Z. The anti-desmoglein 1 autoantibodies in pemphigus vulgaris sera are pathogenic. J Invest Dermatol. 1999 May;112(5):739–43. doi: 10.1046/j.1523-1747.1999.00585.x. [DOI] [PubMed] [Google Scholar]
- 9.Tope WD, Kamino H, Briggaman RA, Rico MJ, Prose NS. Neonatal pemphigus vulgaris in a child born to a woman in remission. J Am Acad Dermatol. 1993 Sep;29(3):480–5. doi: 10.1016/0190-9622(93)70216-g. [DOI] [PubMed] [Google Scholar]
- 10.Grunwald MH, Zamora E, Avinoach I, et al. Pemphigus neonatorum. Pediatr Dermatol. 1993 Jun;10(2):169–70. doi: 10.1111/j.1525-1470.1993.tb00048.x. [DOI] [PubMed] [Google Scholar]
- 11.Hup JM, Bruinsma RA, Boersma ER, de Jong MC. Neonatal pemphigus vulgaris: transplacental transmission of antibodies. Pediatr Dermatol. 1986 Dec;3(6):468–72. doi: 10.1111/j.1525-1470.1986.tb00653.x. [DOI] [PubMed] [Google Scholar]
- 12.Merlob P, Metzker A, Hazaz B, Rogovin H, Reisner SH. Neonatal pemphigus vulgaris. Pediatrics. 1986 Dec;78(6):1102–5. [PubMed] [Google Scholar]
- 13.Storer JS, Galen WK, Nesbitt LT, Jr, Deleo VA. Neonatal pemphigus vulgaris. J Am Acad Dermatol. 1982 May;6(5):929–32. doi: 10.1016/s0190-9622(82)80127-8. [DOI] [PubMed] [Google Scholar]
- 14.Fainaru O, Mashiach R, Kupferminc M, Shenhay M, Pauzner D, Lessing JB. Pemphigus vulgaris in pregnancy: a case report and review of literature. Hum Reprod. 2000 May;15(5):1195–7. doi: 10.1093/humrep/15.5.1195. [DOI] [PubMed] [Google Scholar]
- 15.Hirsch R, Anderson J, Weinberg JM, et al. Neonatal pemphigus foliaceus. JMet al. J Am Acad Dermatol. 2003 Aug;49(2):623–5. doi: 10.1067/mjd.2003.339. [DOI] [PubMed] [Google Scholar]
- 16.Walker DC, Kolar KA, Herbert AA, Jordon RE. Arch. Neonatal pemphigus foliaceus. Arch Dermatol. 1995 Nov;131(11):1308–11. [PubMed] [Google Scholar]
- 17.Avalos-Diaz E, Olague-Marchan M, Lopez-Swiderski AL, Herrera-Esparza R, Diaz L. Transplacental passage of maternal pemphigus foliaceus autoantibodies induces neonatal pemphigus. J Am Acad Dermatol. 2000 Dec;43:1130–4. doi: 10.1067/mjd.2000.110400. [DOI] [PubMed] [Google Scholar]
- 18.Wu H, Wang ZH, Yan A, et al. Protection against pemphigus foliaceus by Desmoglein 3 in neonates. N Engl J Med. 2000 Jul;343(1):31–35. doi: 10.1056/NEJM200007063430105. [DOI] [PubMed] [Google Scholar]
- 19.Amagai M, Koch PJ, Nishikawa T, Stanley JR. Pemphigus vulgaris antigen (desmoglein 3)is localized in the lower epidermis, the site of blister formation in patients. J Invest Dermatol. 1996 Feb;106:351–5. doi: 10.1111/1523-1747.ep12343081. [DOI] [PubMed] [Google Scholar]
- 20.Moncada B, Kettelsen S, Hernandez-Moctezuma JL, et al. Neonatal Pemphigus vulgaris:role of passively transferred pemphigus antibodies. Br J Dermatol. 1982;106:465–8. doi: 10.1111/j.1365-2133.1982.tb04542.x. [DOI] [PubMed] [Google Scholar]
- 21.Moncada B, Sandoval-Cruz JM, Baranda L, et al. Neonatal Pemphigus. Int J Dermatol. 1989 Mar;28:123–4. doi: 10.1111/j.1365-4362.1989.tb01332.x. [DOI] [PubMed] [Google Scholar]
- 22.Middelkamp Hup JM, Bruinsma RA, Boersma ER, et al. Neonatal Pemphigus vulgaris:transplacental transmission of antibodies. Pediatr Dermatol. 1986;3:468–72. doi: 10.1111/j.1525-1470.1986.tb00653.x. [DOI] [PubMed] [Google Scholar]
- 23.Terpstra H, de Jong MC, Klokke AH. In vivo bound pemphigus antibodies in stillborn infant: passive intrauterine transfer of pemphigus vulgaris. Arch Dermatol. 1979;115:316–19. [PubMed] [Google Scholar]
- 24.Green DE, Maize JC. Maternal pemphigus vulgaris with in vivo bound antibodies in the stillborn fetus. J Am Acad Dermatol. 1982;7(3):388–92. doi: 10.1016/s0190-9622(82)70125-2. [DOI] [PubMed] [Google Scholar]
- 25.Karpati S, Amagai M, Prussick R, et al. Pemphigus vulgaris antigen, a desmoglein type of cadherin, is localized within keratinocyte desmosomes. J Cell Biol. 1993;122:409–15. doi: 10.1083/jcb.122.2.409. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Koulu L, Kusumi A, Steinberg MS, et al. Human autoantibodies against a desmosomal core protein in pemphigus foliaceus. J Exp Med. 1984;160:1509–18. doi: 10.1084/jem.160.5.1509. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Anhalt GJ. Making sense of antigens and antibodies in pemphigus. J Am Acad Dermatol. 1999;40(5 Pt 1):763–6. doi: 10.1016/s0190-9622(99)70161-1. [DOI] [PubMed] [Google Scholar]
- 28.Ruocco V, Rossi A, Astarita C, et al. A congenital acantholytic bullous eruption in the newborn infant of a pemphigus mother. Ital Gen Rev Dermatol. 1975;12:169–174. [Google Scholar]
- 29.Rocha-Alvarez R, Friedman H, Campbell IT, Souza-Aguiar L, Martins-Castro R, Diaz LA. Pregnant women with endemic pemphigus folicaceus(fogo selvagem) give birth to disease-free babies. J Invest Dermatol. 1992;99:78–82. doi: 10.1111/1523-1747.ep12611868. [DOI] [PubMed] [Google Scholar]
- 30.Eyre RW, Stanley JR. Maternal pemphigus foliaceus with cell surface antibody bound in neonatal epidermis. Arch Dermatol. 1988;124:25–7. [PubMed] [Google Scholar]
- 31.Wasserstrum N, Laros RK. Transplacental transmission of pemphigus. JAMA. 1983;249:1480–2. [PubMed] [Google Scholar]
- 32.Yair D, Shenav M, Botchan A, et al. Pregnancy associated with pemphigus. Br J Obstet Gynaecol. 1995;102:667–9. doi: 10.1111/j.1471-0528.1995.tb11410.x. [DOI] [PubMed] [Google Scholar]
- 33.Goldberg NS, DeFeo C, Krishembaum N. Neonatal pemphigus vulgaris and pregnancy:risk factors and recommendations. J Am Acad Dermatol. 1993;28:877–9. doi: 10.1016/0190-9622(93)70123-b. [DOI] [PubMed] [Google Scholar]
- 34.Virgili A, Corazza M, Vesce F, et al. Pemphigus in pregnancy. Acta Derm Venereol. 1995;75:172–3. doi: 10.2340/0001555575172173. [DOI] [PubMed] [Google Scholar]
- 35.Ross MG, Kane B, Frieder R, et al. Pemphigus in pregnancy: a reevaluation of fetal risk. AM J Obstet Gynecol. 1986;155:30–3. doi: 10.1016/0002-9378(86)90071-2. [DOI] [PubMed] [Google Scholar]
- 36.Hern S, Vaughan Jones SA, Setterfield J, et al. Pemphigus vulgaris in pregnancy with favourable foetal prognosis. Clin Exp Dermatol. 1998;23:260–3. doi: 10.1046/j.1365-2230.1998.00370.x. [DOI] [PubMed] [Google Scholar]
- 37.Bjarnason B, Skoglund C, Flosadottir E. Childhood pemphigus vulgaris treated with dapsone. Pediatr Dermatol. 1998;15:381–3. doi: 10.1046/j.1525-1470.1998.1998015381.x. [DOI] [PubMed] [Google Scholar]